Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Brancolini

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Journal of Cellular and Molecular Medicine|March 26, 2011
Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesisAndrea Clocchiatti, Cristina Florean, Claudio Brancolini
The Journal of Biological Chemistry|August 7, 2014
A receptor-interacting protein 1 (RIP1)-independent necrotic death under the control of protein phosphatase PP2A that involves the reorganization of actin cytoskeleton and the action of cofilin-1Andrea Tomasella, Anne Blangy, Claudio Brancolini
Cancer Drug Resistance (Alhambra, Calif.)|December 3, 2024
HDAC-driven mechanisms in anticancer resistance: epigenetics and beyondMartina Minisini, Martina Mascaro, Claudio Brancolini
The Journal of Biological Chemistry|May 9, 2025
ProOvErlap: Assessing feature proximity/overlap and testing statistical significance from genomic intervalsNicolò Gualandi, Alessio Bertozzo, Claudio Brancolini
Cancer Research|January 14, 2010
Identification of USP18 as an important regulator of the susceptibility to IFN-alpha and drug-induced apoptosisHarish Potu, Andrea Sgorbissa, Claudio Brancolini
American Journal of Translational Research|July 1, 2010
Isopeptidases in anticancer therapy: looking for inhibitorsAndrea Sgorbissa, Harish Potu, Claudio Brancolini
Life (Basel, Switzerland)|January 26, 2024
Acetylation and Phosphorylation in the Regulation of Hypoxia-Inducible Factor Activities: Additional Options to Modulate Adaptations to Changes in Oxygen LevelsMartina Minisini, Emanuele Cricchi, Claudio Brancolini
Pharmacology & Therapeutics|April 17, 2022
HDACs and the epigenetic plasticity of cancer cells: Target the complexityClaudio Brancolini, Teresa Gagliano, Martina Minisini
Autophagy|March 10, 2009
Inhibitors of the ubiquitin-proteasome system are not all alike: identification of a new necrotic pathwayCarmela Foti, Francesca Demarchi, Claudio Brancolini
Molecular Oncology|October 14, 2018
Unscheduled HDAC4 repressive activity in human fibroblasts triggers TP53-dependent senescence and favors cell transformationHarikrishnareddy Paluvai, Eros Di Giorgio, Claudio Brancolini
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Journal of Cellular and Molecular Medicine|March 26, 2011
Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesisAndrea Clocchiatti, Cristina Florean, Claudio Brancolini
The Journal of Biological Chemistry|August 7, 2014
A receptor-interacting protein 1 (RIP1)-independent necrotic death under the control of protein phosphatase PP2A that involves the reorganization of actin cytoskeleton and the action of cofilin-1Andrea Tomasella, Anne Blangy, Claudio Brancolini
Cancer Drug Resistance (Alhambra, Calif.)|December 3, 2024
HDAC-driven mechanisms in anticancer resistance: epigenetics and beyondMartina Minisini, Martina Mascaro, Claudio Brancolini
The Journal of Biological Chemistry|May 9, 2025
ProOvErlap: Assessing feature proximity/overlap and testing statistical significance from genomic intervalsNicolò Gualandi, Alessio Bertozzo, Claudio Brancolini
Cancer Research|January 14, 2010
Identification of USP18 as an important regulator of the susceptibility to IFN-alpha and drug-induced apoptosisHarish Potu, Andrea Sgorbissa, Claudio Brancolini
American Journal of Translational Research|July 1, 2010
Isopeptidases in anticancer therapy: looking for inhibitorsAndrea Sgorbissa, Harish Potu, Claudio Brancolini
Life (Basel, Switzerland)|January 26, 2024
Acetylation and Phosphorylation in the Regulation of Hypoxia-Inducible Factor Activities: Additional Options to Modulate Adaptations to Changes in Oxygen LevelsMartina Minisini, Emanuele Cricchi, Claudio Brancolini
Pharmacology & Therapeutics|April 17, 2022
HDACs and the epigenetic plasticity of cancer cells: Target the complexityClaudio Brancolini, Teresa Gagliano, Martina Minisini
Autophagy|March 10, 2009
Inhibitors of the ubiquitin-proteasome system are not all alike: identification of a new necrotic pathwayCarmela Foti, Francesca Demarchi, Claudio Brancolini
Molecular Oncology|October 14, 2018
Unscheduled HDAC4 repressive activity in human fibroblasts triggers TP53-dependent senescence and favors cell transformationHarikrishnareddy Paluvai, Eros Di Giorgio, Claudio Brancolini
Pageof 8